 |
Partners' Directory |
| Home Search Join the Partnership Login | |
| Contact | General | Specializations in Countries | Contribution to the Global Plan | Declaration |
View this partner's profile
Organization Contact Information | |
| Name: | Mott MacDonald Ltd |
| Street 1: | 10 Fleet Place |
| Street 2: | |
| City: | London |
| Province: | |
| Post Code: | EC4M 7RB |
| Country: | United Kingdom of Great Britain and Northern Ireland |
| Phone: | +44 (0) 207 651 0302 |
| Organization Email: | viv.wight@mottmac.com |
| Web Site: | http://www.mottmac.com |
| Other Online Presence: | |
|
|
||||||||||||||||||||||||||||
General Information | |
| Board Constituency: | Private sector |
| Is your organization legally registered in your country: | Yes |
| If yes, please enter your registration number: | |
| Organization Type - Primary: | Private Sector |
| Organization Type - Secondary: | Company |
| Organization Description: | |
| HLSP provides health sector consultancy, programme management and policy advice to international agencies and national governments in developing countries. Our expertise ranges from health systems strengthening to cross-cutting issues related to aid effectiveness. HLSP is supported by an in-house team of technical specialists and 8000 external consultants offering a broad range of health sector skills including health policy and planning, sector financing, governance, gender, and capacity development. Our expertise includes: identifying target and risk groups designing disease control programmes and supporting the integration of disease control interventions into health systems strengthening efforts adapting the financing of communicable disease control to broader health sector financing modalities evaluating financial and technical support for communicable diseases Examples: Regional Public Goods for Health: Combating Dengue in ASEAN Mozambique: Appraisal of the DFID-Funded Insecticide Treated Nets Distribution Partnerships for Malaria Control: Engaging the Formal and Informal Private Sectors Independent Evaluation of the Global Outbreak Alert and Response Network (GOARN) South Africa: Development and Field Testing of WHO Tuberculosis Costing Tool South Africa: Rapid Response Health Fund (TB) Review of the International Union against TB & Lung Disease, Review of STOP TB Partnership We have previous experience of TB control namely: Independent external evaluation of the Global Stop TB Partnership Commissioned by the Stop TB Partnership Secretariat at WHO, 2003 and we are currently involved in a TB Reach project together with the Royal Tropical Institute. |
|
| Do you know about the UNHLM declaration: | |
Specializations / Areas of Work | |
|
Advocacy Funding, including innovative and optimized approach to funding TB Care Research and Development Technical Assistance |
Other Organization Information | |
| Total number of staff in your organization: | 100 + |
| Number of full-time staff who are directly involved with TB: | 1 - 5 |
| Number of part-time staff who are directly involved with TB: | 1 - 5 |
| Number of volunteers who are directly involved with TB: | 0 |
| How did you hear about the Stop TB Partnership: | Stop TB communications |
| If you were informed or referred by another partner of the Stop TB Partnership please tell us who: | |
| Why do you wish join the Stop TB Partnership: | Technical assistance and advice |
| Are you a member of a Stop TB national partnership: | No |
| Are you in contact with your national TB programme: | No |
| Please tell us how your organization is contributing to your country's national TB control plan: | |
| External Review of Grant Framework for Public-Private Product Development Partnerships Region: - Country: - Client: Ministry of Foreign Affairs, The Netherlands Date: 2009 In 2006, the Netherlands Ministry of Foreign Affairs awarded eight grants to public-private Product Development Partnerships (PDPs) working on the development of medicines, vaccines and diagnostics for AIDS, TB and malaria. PDPs bring together public and private partners to work towards a common goal of developing new and improved health technologies to address the world’s most neglected diseases. HLSP was contracted to review the grant mechanism to assess the effectiveness and efficiency of the use of the Dutch funds and their impact on each PDP. Technical area: Access to medicines Monitoring and evaluation Private sector Independent external evaluation of the Global Stop TB Partnership Region: - Country: - Client: Stop TB Partnership Secretariat at WHO Date: 2003 HLSP conducted an external evaluation of the Partnership's relevance, efficacy, efficiency, sustainability, institutional development impact, process, governance and implementation. The evaluation included country case studies (Russian Federation, Cambodia, South Africa, Indonesia, Brazil, Afghanistan). Read the evaluation report. Technical area: Monitoring and evaluation TB, malaria and other communicable diseases |
|
Geographical Reach | |
| Which country is your headquarters located in: | United Kingdom of Great Britain and Northern Ireland |
| Which countries do you do operate in: (This includes countries you are conducting activities in) |
Albania Australia Bangladesh Belize Bosnia and Herzegovina Cambodia India Kazakhstan Kenya Nepal Netherlands Nigeria Pakistan Philippines South Africa United Kingdom of Great Britain and Northern Ireland Viet Nam Zambia |
Contribution | |
| Please tell us how your organization will contribute to the Global Plan to Stop TB by briefly describing its involvement in any of the areas of work listed below: | |
|
TB Care Delivery: Along with KIT, we carry out the monitoring and evaluation of TB REACH grantees' projects (waves 1-3). The expansion and enhancement aspect is reflected in TB-REACH's objectives of increasing case detection, treatement and cures, using innovative or tried and tested ways of reaching previously unreached populations. |
|
Declaration | |
| Declaration of interests: No conflicts of interest were delacred. | |
| Application date: | September 27, 2010 |
| Last updated: | May 3, 2017 |